You are comparing large cap blue chip shares with a spec stock....

You are comparing large cap blue chip shares with a spec stock. Honestly, your understanding of the market is NQR.

UCM could double and still be a fraction of the market cap of the stocks you list. No one in the market bench marks spec against blue chip.

Maybe try it against other spec bio-tech stocks to get a true comparison.

Honestly mate, you seem to have very little understanding of anything to do with the market. You see manipulation where there is none and now you think UCM is comparable to blue chip shares with market caps in the billions of dollar range.